U.S. Markets close in 3 hrs 55 mins

Ionis Pharmaceuticals Inc (IONS) Chairman and CEO Stanley T Crooke Sold $1.6 million of Shares

Chairman and CEO of Ionis Pharmaceuticals Inc (30-Year Financial, Insider Trades) Stanley T Crooke (insider trades) sold 22,000 shares of IONS on 08/21/2019 at an average price of $71.52 a share. The total sale was $1.6 million.

Ionis Pharmaceuticals Inc is the RNA-targeted drug discovery and development company. Its broad pipeline consists of close to 32 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe, and rare diseases. Ionis Pharmaceuticals Inc has a market cap of $9.53 billion; its shares were traded at around $67.85 with a P/E ratio of 24.32 and P/S ratio of 11.97. GuruFocus has detected 3 severe warning signs with Ionis Pharmaceuticals Inc. .

CEO Recent Trades:

  • Chairman and CEO Stanley T Crooke sold 22,000 shares of IONS stock on 08/21/2019 at the average price of $71.52. The price of the stock has decreased by 5.13% since.

For the complete insider trading history of IONS, click here

.This article first appeared on GuruFocus.